Home › Funds › Occam Crest Management LP › NVCT
Occam Crest Management LP position in NVCT
NUVECTIS PHARMA INC · Health Care
Occam Crest Management LP reported holding 2,800 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 1.75% of its reported portfolio and ranking #17 among its reported holdings. Occam Crest Management LP has disclosed NVCT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Occam Crest Management LP's NVCT position evolved
Occam Crest Management LP first disclosed a stake in NVCT in Q3 2025 at 290,000 shares (US$1.7M). The position peaked in Q2 2026 at 4,800 shares, worth US$5.2M. Across 5 filings, Occam Crest Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,800 shares valued at US$3.1M — a reduction of -2,000 shares quarter over quarter.. Notable position changes include a 31% increase in Q4 2025 (shares rose 2% over the following quarter), a 99% trim in Q2 2026 (shares rose 15% over the following quarter), a 42% trim in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 290.00K | $1.75M | New |
| Q4 2025 | 380.00K | $2.87M | Add |
| Q1 2026 | 407.15K | $3.15M | Add |
| Q2 2026 | 4.80K | $5.16M | Reduce |
| Q3 2026 | 2.80K | $3.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVCT and 13F data
NVCT (NUVECTIS PHARMA INC) is a Health Care company. 63 other funds we track also report a position in NVCT — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$28.5M), Soleus Capital Management, L.P. (US$18.4M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCT
- TANG CAPITAL MANAGEMENT LLC 1.55M sh · $28.50M · Q2 2026
- Soleus Capital Management, L.P. 1.00M sh · $18.39M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 793.21K sh · $16.75M · Q3 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K sh · $8.07M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 382.94K sh · $7.04M · Q2 2026
- Avidity Partners Management LP 200.00K sh · $3.68M · Q2 2026
- Squadron Capital Management LLC 38.70K sh · $711.69K · Q2 2026
More on Occam Crest Management LP
FAQ
How long has Occam Crest Management LP held NVCT?
Occam Crest Management LP has disclosed NVCT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Occam Crest Management LP's current position in NVCT?
As of Q3 2026, Occam Crest Management LP holds 2.80K shares of NVCT (NUVECTIS PHARMA INC), valued at $3.09M, representing 1.75% of its reported portfolio and ranking #17.
Has Occam Crest Management LP been buying or selling NVCT?
In the latest 13F filing (Q3 2026), Occam Crest Management LP reduced its position in NVCT. The position peaked in Q2 2026 at 4.80K shares.
Which other funds hold NVCT?
Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., IRIDIAN ASSET MANAGEMENT LLC/CT, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.